Bravatek Solutions Inc (BVTK)

[JNickel1]

Background
Dr. Thomas A. Cellucci, also known as Tom, Ph.D., MBA, has been the Chief Executive Officer of Ecrypt Technologies, Inc. since June 13, 2014 and has been its Chairman since March 17, 2015. Dr. Cellucci founded Cellucci Associates, Inc. in 1999 and serves as its Chief Executive Officer and President. Dr. Cellucci served as President and Chief Operating Officer of Zyvex Corporation until June 2006. From 1987 to 2006, he served as Chief Marketing Officer and Vice President of Products of at Zyvex Corporation. Dr. Cellucci has extensive experience in managing and leading hi-tech companies, having served in a variety of senior executive and director positions, for example, as Executive Vice President & General Manager of Integrated Dynamics Engineering and various executive staff and management positions at the Newport Corporation. He served as President and Chief Executive Officer of Etec Inc. Dr. Cellucci was an early pioneer in advancing the field of nanotechnology in American science, engineering and manufacturing. He was instrumental in progressing America’s nanotechnology agenda through his bi-partisan work with President Bill Clinton and George W. Bush and many leaders in the United States Senate. His contributions made possible the National Nanotechnology Initiative (NNI) signed by President George W. Bush in 2004 that added over $3.9 billion to the federal budget specific to the advancement of nanotechnology. From July 2007 to 2011, Dr. Cellucci served as the US Federal Government’s first ever Chief Commercialization Officer at the US Department of Homeland Security (DHS) and the White House, working directly for President George W. Bush and President Barack Obama. There he expanded the role of public-private partnerships within government and increased opportunities for cooperative research and development activities in support across government. As Chief Commercialization Officer, Dr. Cellucci was responsible for initiatives that identified, evaluated and commercialized technology for the specific goal of rapidly developing and deploying products and services that meet the specific operational requirements of DHS’s operating components, first responders and critical infrastructure/key resources owners and operators. Dr. Cellucci’s outreach with both the private and public sectors to establish and foster mutually-beneficial working relationships that facilitated cost-effective and efficient product, service and technology development efforts was viewed as goal for all federal agencies. In 2010, while continuing to serve as Chief Commercialization Officer, Dr. Cellucci was asked to serve as Director of the Office of Public-Private Partnerships and was responsible for the effective integration of the Long Range Broad Agency Announcement (LRBAA) procurement process, Office of SAFETY Act Implementation (OSAI), Small Business Innovation Research (SBIR) Office as well as the Commercialization Office. In addition, he was asked to serve as the Director of the Research & Development Partnerships (RDP) Group to integrate and leverage the more than $9B in DHS assets and the expertise of more than 1400 team members through the group’s investments in national labs, universities, international partners, special programs and the private sector and government interagency partners to deliver solutions for the Homeland Security Enterprise (HSE). After using his integration and management skills to form a cohesive RDP group, he was then asked to serve as a Senior Counselor. He is an accomplished serial entrepreneur, seasoned senior executive and Board member possessing extensive corporate and Venture Capital experience across a number of worldwide industries. Since 2013, Dr. Cellucci has been the Executive Director at AGVE (Alliance for Government Virtual Engagements) located in Washington DC. Dr. Cellucci has been a Director of Ecrypt Technologies, Inc. since March 27, 2014, Eurasian Economic Club of Scientists since September 2014 and Registrant since 1999. Dr. Cellucci serves as Director of California Molecular Electronics Corporation. He serves as Member of Advisory Board of Boston Analytics, Inc. Dr. Cellucci serves as Advisory Board member of ASME. He serves as Directors of the Laser Institute of America and a member of the Senatorial Trust. He served as a Director of Zyvex Corporation. He has also attended and lectured at executive programs at the Harvard Business School, MIT Sloan School, Kellogg School and others. From 1978 to 1991, Dr. Cellucci was Chemistry Lecturer at Fordham University, the University of Pennsylvania and Princeton University, as well as Professor of Physics and Laser/Electro-Optic Technology at Camden County College. He serves on both public and private Boards and has authored or co-authored over 120 articles on Nanotechnology, Laser physics, Photonics, Environmental disturbance control, MEMS test and measurement, Mistake-proofing enterprise software and Sales & Marketing. He published at DHS alone, eight comprehensive books dealing with the development of operational requirements and innovative public-private partnerships in additional to over 26 articles and other resources that facilitate communication both across government and between the public and private sectors. He co-authored ANSI Standard Z136.5 “The Safe Use of Lasers in Educational Institutions. He is often asked to serve as keynote speaker at both business and technical events around the world. He has received numerous awards and citations from industry, government and business. Dr. Cellucci is the first ever U.S. Federal Government representative to the Council on Competitiveness, a prestigious group of senior executives and thought leaders in business and academia focused on ensuring the global competitiveness of the US in technology, innovation, education and industry. Dr. Cellucci holds a Ph.D. in Physical Chemistry from the University of Pennsylvania (1984), an MBA from Rutgers University (1991), and a B.S. in Chemistry from Fordham University (1980).
Collapse Detail
http://www.bloomberg.com/research/stocks/private/person.asp?personId=2728081&privcapId=50207322